Browse All

Current Filters

CLEAR FILTER x

TITLE

Assessing Neuropsychology Testing Variation at Level IV Epilepsy Centers

Author:Landazuri, Patrick   Gess, Jennifer   Denney, David   Folley, Bradley   Lobue, Christian   Sutcliffe, Melissa   Abel, Taylor   Baumgartner, James   Neimat, Joseph   Palys, Viktoras   Pearson, Caleb   

Session Name:P1: Epilepsy/Clinical Neurophysiology (EEG): Neuropsychiatry  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P1.001  

Author Institution:University of Kansas Medical Center, Kansas City, KS  University of Arkansas for Medical Sciences, Little Rock, AR  University of Texas Southwestern Medical Center, Dallas, TX  Norton Neuroscience Institute, University of Kentucky, Louisville, KY  University of Pittsburgh Medical Center, Pittsburgh, PA  Advent Health for Children, Orlando, FL  University of Louisville, Louisville, KY  

Therapeutic Challenges of Huntington's Disease in Guinea: Study of HD Confirmed Cases in a Country with Limited Resources

Author:Carlos Othon, GUELNGAR   Muthinja, Mendi Julianne   Rizig, Mie   Cisse, Abass Fode   cisse, Amara   

Session Name:P2: Movement Disorders: Huntington's Disease and Chorea 2  

Topic:Movement Disorders  

Program Number:P2.013  

Author Institution:National Ignace Deen Hospital, University of Conakry, Conakry, Guinea, Conakry, Guinea  Huntington disease Africa, Nairobi, Kenya  Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK, London, United Kingdom  

Cognitive Impairment in Liver Transplant Recipients =3 Months After Transplant

Author:Berry, Ketura   Barry, Fawzy   Shui, Amy   Wong, Randi   Seetharaman, Sri   Kent, Dorothea   Ruck, Jessica   Vandvrede, Lawren   Lai, Jennifer   

Session Name:P4: General Neurology: Encephalopathy  

Topic:General Neurology  

Program Number:P4.006  

Author Institution:UCSF, San Francisco, CA  Johns Hopkins, Baltimore, MD  

Comparison of 2-year Teriflunomide Outcomes between DMT-naive and switch patients with Relapsing MS: subanalysis of the Real-World TERICARE study

Author:Meca Lallana, Jose   Prieto, Jose María   Caminero, Ana Belén   Olascoaga, Javier   Casademont Portell, Rosa   Forner, Mireia   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.003  

Author Institution:Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, Murcia, Spain  Complejo Hospitalario Universitario de Santiago de Compostela, Spain, Santiago de Compostela, Spain  Complejo Asistencial de Ávila, Spain, Ávila, Spain  Hospital Universitario Donostia, Spain, Donostia-San Sebastián, Spain  Sanofi, Barcelona, Spain, Barcelona, Spain  

Rivaroxaban for the treatment of cerebral venous thrombosis

Author:Mirzaasgari, Zahra   Esmaeili, Sara   Mojtahed, Mohammad   Zabeti, Aram   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.020  

Author Institution:Department of Neurology, University of Cincinnati  Department of Neurology, Iran University of Medical Sciences